K.M. Rentsch
Comparative pharmacokinetic and cytotoxic analysis of three different formulations of mitoxantrone in mice
Rentsch K, Horber D, Schwendener R, Wunderli-Allenspach H, Haenseler E. Comparative pharmacokinetic and cytotoxic analysis of three different formulations of mitoxantrone in mice. Br J Cancer 1997; 75:986-992.
Jan 1, 1997Comparative pharmacokinetic and cytotoxic analysis of three different formulations of mitoxantrone in mice
Jan 1, 1997Br J Cancer 1997; 75:986-992
Rentsch K.M., Horber Daniel, Schwendener R., Wunderli-Allenspach H., Haenseler E.
Monograph: Alkasar-18, 1-(beta-D-arabinofuranosyl)-4-octadecylamino-2(1H)-pyrimidin-one, N4-octadecyl-ara-C, NOAC
Schwendener R, Horber D, Ottiger C, Rentsch K, Fiebig H, Schott H. Monograph: Alkasar-18, 1-(beta-D-arabinofuranosyl)-4-octadecylamino-2(1H)-pyrimidin-one, N4-octadecyl-ara-C, NOAC. Drugs of the Future 1995; 20:11-15.
Jan 1, 1995Monograph: Alkasar-18, 1-(beta-D-arabinofuranosyl)-4-octadecylamino-2(1H)-pyrimidin-one, N4-octadecyl-ara-C, NOAC
Jan 1, 1995Drugs of the Future 1995; 20:11-15
Schwendener R., Horber Daniel, Ottiger C., Rentsch K.M., Fiebig H.H., Schott H.
Preclinical and clinical experience with liposome encapsulated mitoxantrone
Schwendener R, Horber D, Rentsch K, Haenseler E, Pestalozzi B, Sauter C. Preclinical and clinical experience with liposome encapsulated mitoxantrone. J Liposome Res 1994; 4:605-639.
Jan 1, 1994Preclinical and clinical experience with liposome encapsulated mitoxantrone
Jan 1, 1994J Liposome Res 1994; 4:605-639
Schwendener R., Horber Daniel, Rentsch K.M., Haenseler E., Pestalozzi B., Sauter C.